share_log

啓明醫療-B：致非登記持有人之通知信函 - 2023 年度報告之發佈通知及回條

VENUS MEDTECH-B: Notification Letter to Non-Registered Holders - Notice of Publication of 2023 Annual Report and Reply Form

Hong Kong Stock Exchange ·  Apr 29 09:10
Summary by Moomoo AI
啓明醫疗宣布其2023年度報告已於2024年4月30日發布，並可於香港交易所及公司網站上獲得。該報告提供中英文版本，以符合香港交易所上市規則第2.07條於2023年12月31日生效的無紙化及電子發布要求。非登記股東如需印刷版報告，可透過電郵或書面方式向H股股份過戶處提出申請。公司亦提醒非登記股東，若需收取未來的可供採取行動的公司通訊，應向其股份代理機構提供電郵地址。啓明醫療執行董事林浩昇先生代表董事會發出通知。
啓明醫疗宣布其2023年度報告已於2024年4月30日發布，並可於香港交易所及公司網站上獲得。該報告提供中英文版本，以符合香港交易所上市規則第2.07條於2023年12月31日生效的無紙化及電子發布要求。非登記股東如需印刷版報告，可透過電郵或書面方式向H股股份過戶處提出申請。公司亦提醒非登記股東，若需收取未來的可供採取行動的公司通訊，應向其股份代理機構提供電郵地址。啓明醫療執行董事林浩昇先生代表董事會發出通知。
Kai Ming Medical announces that its 2023 report has been published on 30 April 2024 and is available on the HKEx and the Company's website. The report is available in Chinese and English to comply with the requirements for paperless and electronic publication in accordance with Section 2.07 of the HKEx Listing Rules effective on 31 December 2023. Non-registered shareholders may apply to the H Shares Account Office by email or in writing if they require a printed version of the report. THE COMPANY ALSO REMINDS NON-REGISTERED SHAREHOLDERS TO PROVIDE AN EMAIL ADDRESS TO THEIR STOCK AGENT IF THEY NEED TO RECEIVE FUTURE CORPORATE COMMUNICATIONS FOR ACTION. A notice was issued on behalf of the Board by Mr Lin Haosheng, Executive Director of Kai Ming Medical.
Kai Ming Medical announces that its 2023 report has been published on 30 April 2024 and is available on the HKEx and the Company's website. The report is available in Chinese and English to comply with the requirements for paperless and electronic publication in accordance with Section 2.07 of the HKEx Listing Rules effective on 31 December 2023. Non-registered shareholders may apply to the H Shares Account Office by email or in writing if they require a printed version of the report. THE COMPANY ALSO REMINDS NON-REGISTERED SHAREHOLDERS TO PROVIDE AN EMAIL ADDRESS TO THEIR STOCK AGENT IF THEY NEED TO RECEIVE FUTURE CORPORATE COMMUNICATIONS FOR ACTION. A notice was issued on behalf of the Board by Mr Lin Haosheng, Executive Director of Kai Ming Medical.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more